Type 1 Diabetes

Latest News

Hip, Nonvertebral Fracture Risk Higher in Patients With Diabetes

Individuals with diabetes have an increased risk for hip and nonvertebral fractures.

Ready-to-Use Glucagon Pen Now Available for Severe Hypoglycemia

By

Brian Park, PharmD

Xeris Pharmaceuticals announced the launch of Gvoke HypoPen™ (glucagon) for the treatment of severe hypoglycemia in pediatric and adult patients with diabetes aged 2 years and older.

Recommendations for Management of Diabetic Ketoacidosis in COVID-19

By

Amit Akirov, MD

A clinical perspective article details the recommended approach to manage diabetic ketoacidosis in patients with diabetes during the COVID-19 pandemic.

Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting

By

Amit Akirov, MD

Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.

Associations Between Pemphigus and Type 1 Diabetes, Type 2 Diabetes

By

Rachael Beairsto

The association of pemphigus with type 1 (T1DM) and type 2 diabetes mellitus (T2DM) is assessed.

Hyperglycemia Common in Patients With T1D and COVID-19

Presentation patterns are similar in patients with type 1 diabetes admitted with confirmed or suspected COVID-19.

Acute Hyperglycemia Impairs Spatial Working Memory in Adolescents With T1D

By

Rose Reeb

Acute hyperglycemia affects brain metabolite concentration and performance on spatial working memory tasks in adolescents with type 1 diabetes.

New Rapid-Acting Insulin Lispro Approved by FDA

By

Brian Park, PharmD

The FDA has approved Lyumjev™ (insulin lispro-aabc injection; Lilly) to improve glycemic control in adults with type 1 and type 2 diabetes.

FDA Approves Long-Acting Insulin Glargine Injection for T1D, T2D

By

Brian Park, PharmD

The FDA has approved Semglee™ (insulin glargine injection; Mylan and Biocon) to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Depression Screening in Pediatric Patients With Type 1 Diabetes

By

Madeline Morr

Researchers implemented an electronic medical record-based depressive symptom screen in type 1 diabetes mellitus adolescents seen in an outpatient clinic.

Lipohypertrophy Diagnosis Often Missed on Physical Examination in Patients With Diabetes

By

Rachael Beairsto

There is a high false-negative rate for lipohypertrophy diagnosis on physical examination in patients with type 1 or type 2 diabetes.

Golimumab May Reduce Insulin Use in Newly Diagnosed Type 1 Diabetes

By

Rachael Beairsto

Golimumab was found to preserve β-cell function and reduce the need for exogenous insulin in young patients with type 1 diabetes.

Use of CGM at Diabetes Camps May Reduce Hypoglycemia in Campers

By

Rachael Beairsto

Use of continuous glucose monitoring significantly decreases rates of hypoglycemia among children and adolescents who attend diabetes camps.

BMI Linked to Tracheal Intubation and Death in Patients With Diabetes, COVID-19

Body mass index (BMI) is associated with tracheal intubation and/or death within seven days among individuals with diabetes hospitalized for COVID-19.

Managing Cardiovascular Risk in Patients With Diabetes and COVID-19

By

Brandon May

The management of cardiovascular risk in patients with diabetes admitted with COVID-19 should be adapted to this population.

Using Smartphone Apps for Glycemic Control in Diabetes: What Improvements Are Still Needed?

By

Madeline Morr

Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.

Regardless of Diabetes Status, Tight Glucose Control Reduces Risk for Severe Disease in COVID-19

By

Morgan E. Meissner

Hyperglycemic patients treated with insulin infusion to maintain tight glucose control were at lower risk for severe disease in COVID-19.

Dasiglucagon Under Review for Severe Hypoglycemia

By

Diana Ernst, RPh

The FDA has accepted for review the New Drug Application for dasiglucagon HypoPal® Rescue Pen (Zealand Pharma) for the treatment of severe hypoglycemia.

New Medicare Benefit Would Limit Insulin Copays to $35 a Month

Reacting to skyrocketing prices for insulin, the Trump Administration announced on Tuesday a new benefit that would limit Medicare recipients’ copays for insulin to a maximum of $35 a month and save them about $446 a year if they have prescription plans that offer the benefit.

Considerations for Hydroxychloroquine Use in Patients With Diabetes

By

Morgan E. Meissner

Careful consideration should be taken before using hydroxychloroquine in patients with diabetes, particularly in the context of COVID-19.